ZT program (DEZHAN HEALTHCARE)

N/A

Report date: 2025/09/16 18:08:02
NME

Base Information

Drug NameZT program (DEZHAN HEALTHCARE)
Drug Alias NameZT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurinergic receptor P2Y12 modulators
TargetsPurinergic receptor P2Y12
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesDezhan Healthcare Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDezhan Healthcare Company Ltd
Inactive CompaniesN/A
Active IndicationsThromboembolism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A